Clinical Trial Update: A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting [Phase 4]

View source ↗

Summary

Phase 4 trial update collecting complementary efficacy, safety, and patient-reported outcomes in active relapsing forms of multiple sclerosis in a pragmatic set…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED